RxDoctor Payments Data

Louis Bley, MD

Orthopaedic Surgery · Somerville, MANPI 1285724526

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $113,537 of the $129,766 with a category attached, or 87.5%. Smith+Nephew accounts for 98.0% of it on its own, with 5 other manufacturers making up the rest. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$129,766in general payments, 2019–2025

Across 51 payments — averaging $2544.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$127K
  • Depuy Synthes Products, Inc.$2K
  • Biofire Diagnostics, LLC$425
  • Acumed LLC$83
  • Pacira Therapeutics, Inc.$53
  • Baxter Healthcare$29

What the payments were for

  • Royalty or licence$113,53787%
  • Consulting fees$14,81911%
  • Speaking & faculty fees$4250%
  • Food & beverage$9841%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$129,766 in reported general payments places this provider in the 90th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$75,672
Medicare patients
229
Services billed
7,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam37$175
Prednisone11$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Somerville

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →